tracking
Rate this Video

Amyloid, Neuropsychiatric Effects on Mild Cognitive Impairment Risk

Dr Janina Krell-Roesch, PhD, discusses her research on the effects of depression and anxiety in cognitively-normal patients. The data was presented at the 2016 American Academy of Neurology Annual Meeting in Vancouver.

To learn more about how amyloid pathology and neuropsychiatric conditions affect MCI risk, go here:
http://www.neurologyadvisor.com/aan-2016-coverage/neuropsychiatric-symptoms-beta-amyloid-elevate-mci-risk/article/491103/
Link
Embed
Email
Comments (0)
Add your comment
Advertisement